FNCHQ (Finch Therapeutics Group) 1-Year Share Buyback Ratio: 0.00% (As of Jun. 2024 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FNCHQ Finch Therapeutics Group Inc FNCHQ
12 GF Score
Price $10.20
View Full Analysis

What is Finch Therapeutics Group 1-Year Share Buyback Ratio?

Finch Therapeutics Group FNCHQ 12 1-Year Share Buyback Ratio is 0.00 as of Jun. 2024. GuruFocus rates FNCHQ with a GF Score™ of 12/100.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Finch Therapeutics Group's current 1-Year Share Buyback Ratio was 0.00%.

FNCHQ's 1-Year Share Buyback Ratio is not ranked *
in the Biotechnology industry.
Industry Median: -14.6
* Ranked among companies with meaningful 1-Year Share Buyback Ratio only.

Finch Therapeutics Group  (OTCPK:FNCHQ) 1-Year Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Finch Therapeutics Group 1-Year Share Buyback Ratio Related Terms

FNCHQ vs CRIS, LSB, RANI: 1-Year Share Buyback Ratio Comparison

For the Biotechnology subindustry, Finch Therapeutics Group's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Finch Therapeutics Group 1-Year Share Buyback Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Finch Therapeutics Group's 1-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Finch Therapeutics Group's 1-Year Share Buyback Ratio falls into.


FNCHQ
12GF Score
Finch Therapeutics Group Inc FNCHQ
1-Year Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Finch Therapeutics Group 1-Year Share Buyback Ratio Calculation

Finch Therapeutics Group's 1-Year Share Buyback Ratio for the quarter that ended in Jun. 2024 is calculated as

1-Year Share Buyback Ratio=(Shares Outstanding (EOP) (Jun. 2023 ) - Shares Outstanding (EOP) (Jun. 2024 )) / Shares Outstanding (EOP) (Jun. 2023 )
=(1.605 - 1.606) / 1.605
=-0.1%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a 1-Year Share Buyback Ratio of 0.00 mean?
Finch Therapeutics Group (FNCHQ) has a 1-Year Share Buyback Ratio of 0.00 as of Jun. 2024. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for Finch Therapeutics Group and its competitors.
Is Finch Therapeutics Group's 1-Year Share Buyback Ratio too high?
Finch Therapeutics Group's current 1-Year Share Buyback Ratio is 0.00. Overall, Finch Therapeutics Group has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Finch Therapeutics Group's 1-Year Share Buyback Ratio compare to CRIS and LSB?
Finch Therapeutics Group's 1-Year Share Buyback Ratio of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Share Buyback Ratio for a Biotechnology company?
A good 1-Year Share Buyback Ratio depends on the Biotechnology industry context. However, 1-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Share Buyback Ratio mean?
A high 1-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for Finch Therapeutics Group and its competitors. Finch Therapeutics Group's current 1-Year Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Finch Therapeutics Group stock overvalued right now?
Finch Therapeutics Group (FNCHQ) has a current 1-Year Share Buyback Ratio of 0.00. The current 1-Year Share Buyback Ratio is 0.00. Finch Therapeutics Group's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Share Buyback Ratio calculated?
1-Year Share Buyback Ratio is calculated from a company's financial statements. For Finch Therapeutics Group (FNCHQ), the current 1-Year Share Buyback Ratio is 0.00 as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Finch Therapeutics Group Business Description

Address 75 State Street, Suite 100, Boston, MA, USA, 02109
Finch Therapeutics Group Inc is a microbiome technology company with a portfolio of intellectual property and microbiome assets. Finch has a robust intellectual property estate reflecting the company's pioneering role in the microbiome therapeutics field, including more than 70 issued U.S. and foreign patents with critical relevance for both donor-derived and donor-independent microbiome therapeutics in a range of potential indications. The company's assets include CP101, an investigational, orally administered microbiome candidate with positive clinical data from a Phase 2 randomized, placebo-controlled trial and a Phase 2 open-label trial in recurrent C. difficile infection (CDI).
12GF Score

Get the complete analysis for FNCHQ

1-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.20
Price